Most Recent
GSK loses patent infringement appeal over slow-release Panadol
Intellectual Property 2018-05-11 9:32 pm By Christine Caulfield

A full bench of the Federal Court has dismissed an appeal by drug giant GlaxoSmithKline in a patent infringement case it brought over planned generic versions of its sustained-release Panadol.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

  1. Pages:
  3. 1
  5. 17
  6. 18
  7. 19
  8. 20
  9. 21
  10. 22
  11. 23
  12. 24